HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It also provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a remote fetal heart rate monitoring solution. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform; and Broward Health for deployment of its HeraCARE to deliver care outcomes for pregnant mothers. HeraMED Limited was founded in 2011 and is based in Camberwell, Australia.
Metrics to compare | HMD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHMDPeersSector | |
---|---|---|---|---|
P/E Ratio | −3.0x | −4.9x | −0.5x | |
PEG Ratio | −0.05 | −0.06 | 0.00 | |
Price/Book | 6.0x | 2.7x | 2.6x | |
Price / LTM Sales | 45.7x | 3.8x | 3.3x | |
Upside (Analyst Target) | - | 101.3% | 43.4% | |
Fair Value Upside | Unlock | 12.2% | 7.1% | Unlock |